GABRB3 and myelodysplastic syndrome: According to findings from “Differences in the methylome profile between good and partial HMA treatment responders,” “Differences in the methylome profile for individuals with MDS progressing to AML,” “Differences in the methylome profile between individuals diagnosed with an excess of marrow blasts (RAEBI or RAEBII)” sections and the interaction map, it is depicted that GABRB3, which harbors DMRs with notable fold change values, potentially interacts with different genes from the PCDHG gene family (Fig. 3D).